Connect Biopharma Holdings (CNTB)

• Market cap: $148M
• 1 day: -0.38%
• 5 days: -5.69%
• 1 month: 60.61%
• 3 months: 33.17%
• 6 months: 226.76%
• Year to date: 119.01%
• 1 year: 138.74%
• 5 years: -85.67%
• 10 years: -85.67%
• Sector: Healthcare
• Industry: Biotechnology

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62